The neonicotinoids restrictions imposed by the European Commission in 2013 present new challenges to farmers. However, due to Bayer’s thiacloprid-based seed-applied product Sonido™, there is an innovative solution available on the market on which some farmers can fall back. An interview with Björn Hardt, Global Key Account Management SeedGrowth at Bayer CropScience, on the benefits of Sonido™ and its market acceptance.
EU’s neonicotinoids restrictions have affected farmers and their businesses. Why can Sonido™ be an adequate solution for some of their problems?

How are farmers responding to this new seed-applied product?

How well is Sonido™ currently accepted in the market?
“Sonido™ was developed and registered just before neonicotinoids were restricted. Since the first registration in France in November 2012, we have received many approvals for Sonido™ throughout Europe in the last two years. It achieved a firm place in the market and was very well adopted especially in France but also other EU countries where maize farmers struggle with wireworms. Meanwhile we are treating well above 1.5 million hectares of corn in Europe with Sonido™. This shows how much growers appreciate this solution.”


